117 KENDRICK STREET, NEEDHAM, MA
Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Candel Therapeutics Elects Four Directors at Annual Meeting
News, Material Contracts
Investor Presentation
Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Annual Report to Security Holders
Financial Results, Press Release
Announces Pricing of Public Offering
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence